Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Moodys
Teva
Queensland Health
Express Scripts
Daiichi Sankyo
Chinese Patent Office
McKesson
US Department of Justice

Generated: May 25, 2018

DrugPatentWatch Database Preview

Triflupromazine hydrochloride - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for triflupromazine hydrochloride and what is the scope of triflupromazine hydrochloride freedom to operate?

Triflupromazine hydrochloride
is the generic ingredient in one branded drug marketed by Apothecon and Bristol Myers Squibb, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for triflupromazine hydrochloride.
Summary for triflupromazine hydrochloride
Synonyms for triflupromazine hydrochloride
10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine monohydrochloride
10-(3-Dimethylaminopropyl)-2-(trifluoromethyl)phenothiazine hydrochloride
10-[3-(Dimethylamino)-1-propyl]-2-(trifluoromethyl)phenothiazine Hydrochloride
10-[3-(Dimethylamino)propyl]-2-(trifluoromethyl)phenothiazine hydrochloride
1098-60-8
10H-Phenothiazine-10-propanamine, N,N-dimethyl-2-(trifluoromethyl)-, monohydrochloride
10H-Phenothiazine-10-propanamine,N-dimethyl-2-(trifluoromethyl)-, monohydrochloride
2767AH
9E75N4A5HM
AC1L24JZ
AKOS024288004
API0004503
C18H19F3N2S
C18H19F3N2S.ClH
CAS-1098-60-8
CCG-213116
CHEBI:9712
CHEMBL1201102
CTK8G3605
D00800
dimethyl({3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl})amine hydrochloride
dimethyl{3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl}amine, chloride
DSSTox_CID_25804
DSSTox_GSID_45804
DSSTox_RID_81142
DTXSID8045804
EINECS 214-149-6
EU-0101146
Flumazin
Fluopromazine monohydrochloride
Fluorofen
FT-0736671
HMS1568K07
HMS1922G15
HY-B0909
J-002339
KS-00001F94
LP01146
LS-105501
MC 4703
MCULE-4776607695
MLS000069672
MLS001148408
MLS002222277
MolPort-003-666-452
N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine;hydrochloride
NCGC00016012-12
NCGC00094410-01
NCGC00094410-02
NCGC00094410-03
NCGC00094410-04
NCGC00094410-05
NCGC00261831-01
Neoprin
Nivoman
NSC 14959
NSC 17473
NSC-14959
NSC-17473
NSC-758387
NSC14959
NSC17473
NSC758387
Opera_ID_486
Pharmakon1600-01503118
Phenothiazine, 10-(3-(dimethylamino)propyl)-2-(trifluoromethyl)-, monohydrochloride
Phenothiazine, 10-(3-dimethylaminopropyl)-2-(trifluoromethyl)-, hydrochloride
Prestwick_893
REGID_for_CID_66069
SBB058191
SCHEMBL317144
SMR000058517
SPECTRUM1503118
SR-01000000224
SR-01000000224-2
SR-01000000224-4
ST51015135
T 2896
Tox21_111276
Tox21_111276_1
Tox21_501146
Trifluopromazine hydrochloride
Trifluopromazine hydrochloride (VAN)
Triflupromazine (hydrochloride)
Triflupromazine HCl
Triflupromazine hydrochloride (JAN/USP)
Triflupromazine hydrochloride [JAN]
Triflupromazine hydrochloride [USP:JAN]
Triflupromazine Hydrochloride 1.0 mg/ml in Methanol (as free base)
Triflupromazine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Triflupromazine hydrochloride, VETRANAL(TM), analytical standard
Triflupromazine monohydrochloride
Triflupromazine(hydrochloride)
UNII-9E75N4A5HM
Vesprin hydrochloride
WLN: T C666 BN ISJ B3N1&1 EXFFF
Z1642388275

US Patents and Regulatory Information for triflupromazine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb VESPRIN triflupromazine hydrochloride TABLET;ORAL 011123-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apothecon VESPRIN triflupromazine hydrochloride INJECTABLE;INJECTION 011325-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apothecon VESPRIN triflupromazine hydrochloride INJECTABLE;INJECTION 011325-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb VESPRIN triflupromazine hydrochloride TABLET;ORAL 011123-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chinese Patent Office
AstraZeneca
Moodys
Argus Health
Federal Trade Commission
Colorcon
Farmers Insurance
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.